Skip to content

Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases

FeNO Result Prediction Factors in Children With Allergic Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00815984
Enrollment
800
Registered
2008-12-31
Start date
2009-01-31
Completion date
2010-01-31
Last updated
2010-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis, Asthma, Atopic Dermatitis

Keywords

Asthma, Allergic Rhinitis, Atopic Dermatitis, Children, lung function, skin prick tests, FeNO

Brief summary

In about 800 children with allergic diseases (asthma, allergic rhinitis, atopic dermatitis) the investigators will retrospectively and cross-sectionally analyze the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Detailed description

In about 800 children with allergic diseases from our Outpatient Clinic (asthma, allergic rhinitis, atopic dermatitis) we will retrospectively and cross-sectionally analyse the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Interventions

PROCEDUREmeasurements of lung function tests

Measurement of the concentration of FeNO , measurement of spirometry, plethysmography, exercise challenge test (ECT -spirometric), bronchial obstruction reversibility pharmacological test

Sponsors

Medical University of Lodz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children with asthma (allergic), and/or allergic rhinitis and/or atopic dermatitis

Exclusion criteria

* Other chronic diseases * Asthma exacerbation * Pregnancy

Design outcomes

Primary

MeasureTime frame
Concentration of nitric oxide in exhaled breath.1-4 months

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026